High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy.
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 13 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
8/11/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=187261783&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 187261783 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 8/11/2025 vid: 27 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 187261783 10.1186/s13058-025-02092-9 187261783 ppf: 1 ppct: 12 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy. aug: au: Parissenti, Amadeo M. Pritzker, Laura B. Dahle, Maria Aanesland Gythfeldt, Hedda von der Lippe Masilamani, Twinkle Theriault, Gabriel St-Onge, Renée D'costa, Lavina Lingjaerde, Ole Christian Haugen, Mads Haugland Engebraaten, Olav affil: https://ror.org/03rcwtr18 School of Natural Sciences, Laurentian University, Sudbury, Canada sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|